Matthew J. Sorrentino

Matthew J. Sorrentino

Cardiology

5758 S. Maryland Ave.
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo.

Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo.

Journal: Journal of the American Heart Association

Published: January 29, 2026

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.

Journal: The Lancet. Neurology

Published: October 24, 2024

The Bucksbaum Institute for Clinical Excellence and the Doctor-Patient Relationship: Origins, Programs, and Future Directions.

The Bucksbaum Institute for Clinical Excellence and the Doctor-Patient Relationship: Origins, Programs, and Future Directions.

Journal: Academic medicine : journal of the Association of American Medical Colleges

Published: February 22, 2023

Preface.

Preface.

Journal: Academic medicine : journal of the Association of American Medical Colleges

Published: February 22, 2023

The Evolution from Hypertension to Heart Failure.

The Evolution from Hypertension to Heart Failure.

Journal: Heart failure clinics

Published: September 02, 2019

Perspective on the New Blood-Pressure Guidelines.

Perspective on the New Blood-Pressure Guidelines.

Journal: European heart journal

Published: April 17, 2019

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.

Journal: Pharmacogenetics and genomics

Published: December 12, 2018

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.

Journal: Neurosurgery

Published: August 29, 2018

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: June 27, 2018

Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.

Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.

Journal: The pharmacogenomics journal

Published: April 26, 2018

Redefining Hypertension - Assessing the New Blood-Pressure Guidelines.

Redefining Hypertension - Assessing the New Blood-Pressure Guidelines.

Journal: The New England journal of medicine

Published: January 18, 2018

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

Journal: Clinical pharmacology and therapeutics

Published: January 16, 2017

Showing 1-12 of 26

Last Updated: 09/26/2026